Company: G
Filing Date: 2025-08-11
Form Type: 10-Q
Source: 0001398659-25-000098
Chunk: 197

Company: Genpact LTD
Filing Date: 2025-08-11
Form: 10-Q
Item: Part I, Item 8
Chunk 197
---
 in millions)Financial Services$100.1 $121.6 21.5 %Consumer and Healthcare137.5 146.4 6.4 %High Tech and Manufacturing143.6 170.1 18.4 %Total reportable segment$381.3 $438.1 14.9 %Unallocated corporate expenses(1.0)(11.1)NM*Adjusted income from operations$380.3 $427.0 12.3 %

*Not Meaningful

AOI of our Financial Services segment, Consumer and Healthcare segment, and High Tech and Manufacturing segment increased by 21.5%, 6.4% and 18.4%, respectively, in the first half of 2025 compared to the first half of 2024, primarily driven by higher revenues and operating efficiency.

AOI for “Unallocated corporate expenses” in the table above primarily represents the adjustment of allowances for credit losses and over- or under-absorption of corporate overheads, which are not allocated to any individual segment for management's internal reporting purposes. See Note 18—“Segment reporting” under Part I, Item 1— “Unaudited Consolidated Financial Statements” above.

60

Liquidity and Capital Resources

Overview

Information about our financial position as of December 31, 2024 and June 30, 2025 is presented below: 

As of December 31, 2024As of June 30, 2025Percentage ChangeIncrease/(Decrease)(dollars in millions)2025 vs. 2024Cash and cash equivalents$648.2 $663.3 2.3%Short-term investments23.4 — NM*Short-term borrowing— 85.0 NM*Current portion of long-term debt 26.2 375.7 NM*Long-term debt, less current portion1,195.3 833.4 (30.3)%Total equity$2,389.6 $2,586.6 8.2%

*Not Meaningful

Financial Condition

We have historically financed our operations and our expansion, including acquisitions, with cash from operations and borrowing facilities. 

On February 8, 2024, our board of directors approved an 11% increase in our quarterly cash dividend from $0.1375 per common share to $0.1525 per common share, representing an annual dividend of